Company news
FibroBiologics, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office
October 15, 2024
FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa
September 29, 2024
FibroBiologics Engages Southern Star Research as CRO in Australia
September 18, 2024
FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology
September 11, 2024
FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology
August 19, 2024
FibroBiologics Files 2024 Second Quarter Report
August 6, 2024
FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
June 24, 2024
FibroBiologics Set to Join Russell 2000® Index
June 12, 2024
FibroBiologics Announces 2024 Annual Meeting of Stockholders
May 14, 2024
FibroBiologics Files 2024 First Quarter Report
May 13, 2024
FibroBiologics to Present at the BIO International Convention 2024
May 6, 2024
FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids
April 24, 2024
FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office
April 10, 2024
FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus
March 27, 2024
FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment
March 18, 2024
FibroBiologics Appoints Ruben A. Garcia as General Counsel
March 5, 2024
FibroBiologics Files 2023 Form 10-K Annual Report
February 28, 2024
FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases
February 12, 2024
FibroBiologics Announces Three United States Patents for Fibroblast Technology
February 7, 2024
FibroBiologics Announces Three Japanese Patents on Fibroblast Technology
February 5, 2024
Decks
- Investor Presentation (September 2026)
Investor deck · 19 slides · September 2026
- Investor Day (December 2023)
Investor day · 33 slides · December 2023